Gold Bond Psoriasis Relief Medicated Multi-Symptom
NDC 41167-0413, Salicylic Acid, cream, from Chattem, Inc..
- Product NDC
- 41167-0413
- Status
- Listed
- Labeler
- Chattem, Inc.
- Dosage form
- CREAM
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M032
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/41167-0413 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SALICYLIC ACID3 g/100g
| Package NDC | NDC-11 | Package |
|---|---|---|
| 41167-0413-2 | 41167041302 | 113 g in 1 TUBE (41167-0413-2) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 41167-0413 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/41167-0413 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 41167-0413. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.